How to Select Fc Gamma Receptor Proteins for Antibody Effector-Function Assays
Fc gamma receptor proteins for antibody effector-function assays should be selected according to receptor subtype, allelic variant, species, expression host, extracellular-domain boundaries, tag and assay format. These choices determine whether a reagent is appropriate for screening antibody–receptor binding, comparing Fc-engineered antibodies or supporting an orthogonal effector-function testing strategy. Beta LifeScience provides recombinant Fc receptor proteins in multiple configurations and offers catalog, semi-custom and custom production routes. Buyers can begin with available FcγR proteins for feasibility studies, then request supported changes or a new construct when an assay requires a different sequence, tag, formulation or quantity.
Beta LifeScience’s broader Fc receptor collection includes Fc gamma receptor proteins alongside other Fc receptor families and related recombinant targets. Confirm the exact receptor family and product specifications before ordering.

Quick Answer
Choose the receptor panel from the antibody’s intended mechanism. CD16a/FCGR3A is central to many ADCC-related binding studies; CD32a/FCGR2A represents an activating FcγRII pathway; CD32b/FCGR2B provides an inhibitory comparator; and CD64/FCGR1A offers a high-affinity Fc-binding reference. Add relevant variants, species orthologs and matched molecular formats when the program requires comparative data. Recombinant binding data characterize molecular interaction and support assay development. Cellular effector function should be evaluated with an application-appropriate functional assay when that is the study endpoint.
Featured Fc Gamma Receptor Proteins and Purchasing Routes
The products below illustrate several FcγR purchasing options. Prices and availability can change; made-to-order status means production timing should be reconfirmed before planning a study.
|
Product |
CAT# |
Key listed configuration |
Best-fit purchasing use |
Listed purchasing status |
Action |
|
Human FcγRIIIA/CD16a V176 Recombinant Protein |
BLK-03066P |
HEK293; Gly17–Gln208 (V176); C-terminal His; >95% purity by Bis-Tris PAGE and HPLC |
Defined mammalian-expressed CD16a V176 starting format |
Online inquiry; size and price confirmation required |
|
|
Recombinant Human FcγRIIIA/FCGR3A/CD16a Protein |
BLT-05852P |
Mammalian; sequence 17–208 (176); C-terminal 6His |
CD16a research and assay-development evaluation |
Listed at $556 for 100 µg; made-to-order product |
|
|
Recombinant Human FCGR3B Protein |
BLT-05856P |
Mammalian; sequence 20–208; N-terminal 6His |
CD16b comparison, neutrophil-associated receptor research and assay development |
Listed at $556 for 100 µg; made-to-order product |
|
|
Recombinant Human FCGR2A Protein |
BLT-08449P |
E. coli; sequence 70–310; N-terminal 6His |
Bacterial recombinant FCGR2A format for research and assay-development evaluation; confirm activity and assay compatibility for the intended binding platform |
Listed at $556 for 100 µg; made-to-order product |
|
|
Semi-custom protein configuration |
Eligible production-optimized protein |
Supported changes may include tag, buffer, formulation, concentration, endotoxin level or packaging |
Existing eligible protein requiring an adjusted configuration |
Price and production timing should be reconfirmed |
|
|
Fully custom protein expression |
Project-specific |
New gene-level construct, sequence, ortholog, fusion or complex |
Receptor format not matched by an available or eligible semi-custom product |
Feasibility, scope, price and timeline confirmed by quotation |
Pricing was reviewed on September 18, 2026 and may change by product status, configuration or quantity. Reconfirm current price, pack size, availability and lead time before ordering.
Need Fc gamma receptor proteins for an antibody binding or effector-function program?
Submit the required receptor subtypes, variants, species, assay platform, tags and quantities. Beta LifeScience can review catalog matches and evaluate semi-custom or fully custom routes.
Match the Receptor Panel to the Antibody Mechanism
A focused panel is usually more informative than selecting receptors only because they are available. Begin with the Fc-mediated mechanism being investigated, then add a receptor only when it answers a defined comparison.
|
Research question |
Receptor to evaluate |
Why it belongs in the panel |
Important buying check |
|
ADCC-related Fc interaction |
FcγRIIIA/CD16a |
Major activating receptor associated with NK-cell-mediated antibody responses |
Variant numbering, sequence boundaries, host and activity documentation |
|
Activating FcγRII binding |
FcγRIIA/CD32a |
Supports comparison of activating FcγRII engagement |
Allelic form, domain construct and glycosylation context |
|
Inhibitory Fc interaction |
FcγRIIB/CD32b |
Provides an inhibitory counterpart to activating receptors |
Exact subtype identity; do not purchase by “CD32” name alone |
|
High-affinity Fc reference |
FcγRI/CD64 |
Supports high-affinity Fc-binding characterization |
Species, extracellular domain and assay-compatible tag |
|
CD16 family specificity |
FcγRIIIA/CD16a plus FcγRIIIB/CD16b |
Helps distinguish closely related receptor interactions |
Confirm FCGR3A versus FCGR3B sequence and intended biological context |
|
Translational comparison |
Human and model-species orthologs |
Supports preclinical-to-human comparison |
Species-specific sequence, format alignment and demonstrated assay suitability |
This mechanism-first approach also keeps the purchasing list manageable. An early feasibility panel may contain one or two receptors, while lead characterization may justify activating, inhibitory, high-affinity and variant-specific comparators.

Verify Receptor Subtype and Variant
Fc receptor naming can create ordering errors. CD32 may refer to FcγRIIA, FcγRIIB or FcγRIIC, and CD16 can refer to FcγRIIIA or FcγRIIIB. Always confirm the gene symbol, protein name and sequence rather than relying on a CD designation alone. Variant numbering requires similar care. CD16a polymorphisms may be reported with different numbering conventions, including V158/F158 or V176/F176. The construct sequence on the product page should be the final reference for selecting matched variants. For CD32a comparisons, verify the stated allelic position and amino acid rather than assuming two products use the same convention.
When comparing variants, keep the remaining features aligned wherever practical:
- Species and extracellular-domain boundaries
- Expression host and glycosylation context
- Tag identity and position
- Purification and formulation
- Receptor loading or immobilization density
- Antibody lot and concentration series
Changing several attributes at once makes a binding difference difficult to assign to the variant itself.
Select the Expression Host and Molecular Format
Mammalian-expressed Fc receptors
Choose mammalian expression when extracellular folding and mammalian-type processing are important to the assay design. This is often the preferred starting route for FcγR binding studies because Fc receptors are glycoproteins and host-dependent processing can influence recombinant-protein behavior. BLK-03066P is a useful example: its listed sequence, HEK293 host, C-terminal His tag and purity specifications make it a strong starting option when a defined, mammalian-expressed CD16a V176 construct is required. Activity and endotoxin claims should be taken from the current product documentation or lot-specific COA before they are included in a regulated internal specification.
Bacterial recombinant formats
An E. coli-expressed receptor can be useful for research screening, antibody generation or assays that do not require mammalian glycosylation. It should not be treated as interchangeable with a mammalian-expressed version. Compare folding, solubility, aggregation, binding performance and compatibility with the intended platform. For BLT-08449P, the appropriate commercial positioning is a bacterial recombinant FCGR2A format for research and assay-development evaluation. Buyers should confirm activity evidence and platform compatibility rather than assuming that receptor identity alone guarantees performance.
Tags and biotinylation
His-tagged receptors can support metal-chelate or anti-His capture, detection and purification workflows. Check tag position because orientation may influence surface access. If other assay components also carry His tags, select a capture and detection strategy that avoids ambiguity. Biotinylated or Avi-tagged proteins can support streptavidin-based immobilization. An Avi tag identifies a biotinylation sequence but does not by itself prove that the supplied protein has been biotinylated. Confirm the product’s biotinylation status, labeling method and relevant quality information.
Fc-tagged receptor formats require extra caution in an assay that already contains an antibody Fc. The fusion can introduce Fc-dependent background or multivalent interactions. Use an appropriate control and select a different tag when the receptor Fc would interfere with the intended measurement.
Choose the Receptor Format for ELISA, SPR or BLI
Plate-based assays can support screening and relative binding comparisons when coating, capture orientation, blocking and detection are controlled. They are useful for ranking samples but may be sensitive to surface density and avidity. SPR and BLI can provide association, dissociation and affinity information. Match the receptor tag to the sensor or capture chemistry, control immobilization level and use an analyte range appropriate for the expected interaction. Regeneration conditions should preserve the captured receptor and maintain response across cycles.
Across platforms, compare samples under a common assay design. Use the same receptor construct, capture strategy, loading target, buffer, antibody preparation and fitting approach. Include a reference surface or blank and any positive or negative antibody controls required for interpretation.

Build a Comparable Effector-Function Reagent Panel
A practical development sequence is:
- Screen a small receptor panel matched to the proposed mechanism.
- Confirm performance with fresh dilutions and independent repeats.
- Add relevant allelic variants or species orthologs.
- Compare Fc-engineered antibodies using the same receptor lots and assay setup.
- Connect molecular binding data with an appropriate cellular functional assay.
For an ADCC-focused program, the panel may begin with CD16a and its relevant variants, then add CD32a, CD32b or CD64 when broader activating, inhibitory or high-affinity context is needed. CD16b can be included when specificity across the closely related CD16 receptors matters.
Quality and Documentation to Review Before Ordering
The product name is only the starting point. Review the specifications that affect assay performance and reproducibility.
|
Purchasing check |
What to confirm |
Why it matters |
|
Identity |
Gene, receptor subtype, species and sequence boundaries |
Prevents selection of the wrong CD32 or CD16 family member |
|
Variant |
Amino-acid substitution and numbering convention |
Enables valid polymorphism comparisons |
|
Expression host |
Mammalian, bacterial or another system |
Affects folding, processing and assay comparability |
|
Tag and position |
His, Avi, biotin or other configuration |
Determines capture chemistry and orientation |
|
Purity and aggregation |
Method, reported result and lot documentation |
Supports consistent immobilization and interpretation |
|
Biological activity |
Assay method and result for the supplied format |
Shows whether activity was evaluated in a relevant configuration |
|
Formulation |
Buffer, stabilizers and concentration |
Affects dilution, storage and platform compatibility |
|
Endotoxin |
Stated limit when relevant |
Important for cell-based follow-up and sensitive applications |
|
Supply status |
Catalog, made-to-order, inquiry or custom |
Determines purchasing steps and lead-time risk |
For longer programs, estimate total usage across optimization, replicates, receptor panels and repeat studies. Ask whether a single lot, bulk quantity or dedicated production plan is appropriate. Made-to-order products can be commercially useful, but their production timing should be included in the assay schedule.
Catalog, Semi-Custom or Fully Custom?
Choose a catalog product when the receptor subtype, sequence, host, tag, activity documentation and quantity match the assay. This is generally the fastest route for feasibility testing. Use semi-custom protein production when an eligible protein from the Production-Optimized Proteins Collection needs a supported adjustment such as a tag, tag position, buffer, formulation, concentration, endotoxin target or packaging configuration. Eligibility and scope must be confirmed. Request fully custom protein expression when the project requires a new gene-level construct, unavailable ortholog, novel variant, fusion, complex or coordinated matched panel. Share the sequence and acceptance criteria early so feasibility, expression route, purification and an appropriate analytical package can be defined in the quotation.

Start Your Fc Gamma Receptor Protein Project
Beta LifeScience can support catalog selection and evaluate semi-custom or fully custom Fc receptor formats. Submit the antibody subclass and Fc modifications, required receptor subtypes and variants, species, construct boundaries, preferred host, tag, assay platform, quantity and analytical expectations. The technical team can identify available catalog matches and confirm the feasible production and QC scope for nonstandard requirements.
Request an Fc Gamma Receptor Feasibility Review and Quote
FAQs
Which Fc gamma receptor is most relevant to ADCC studies?
FcγRIIIA/CD16a is a central receptor for many ADCC-related antibody programs. Select the relevant variant and confirm its sequence, host, tag and assay activity. Molecular binding data should be paired with a cellular assay when functional ADCC is the endpoint.
Should I test more than one Fc gamma receptor?
Use a focused panel when the mechanism involves more than one receptor or when activating-versus-inhibitory balance matters. CD16a, CD32a, CD32b and CD64 answer different questions; include only those that support a defined decision.
Are CD16a V158/F158 and V176/F176 different variants?
They may represent alternative numbering conventions for the same CD16a polymorphic site. Confirm the product sequence and the manufacturer’s stated numbering before building a matched comparison.
Can bacterial and mammalian Fc receptor proteins be compared directly?
They can be evaluated as different recombinant formats, but a host change may alter folding, processing and binding behavior. Interpret the result as a host-dependent comparison unless the relevant attributes are independently controlled.
What should I send for a custom Fc receptor quotation?
Provide the receptor name and species, sequence or accession, domain boundaries, variant, preferred host, tag, required quantity, assay platform, formulation and requested acceptance criteria. Beta LifeScience can then confirm feasibility, available testing, price and estimated timing.